Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Lindner, AK; Lackner, F; Tymoszuk, P; Barth, DA; Seeber, A; Kocher, F; Toth, B; Hochleitner, M; Pichler, M; Pichler, R.
Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy
BIOL SEX DIFFER. 2023; 14(1): 38
Doi: 10.1186/s13293-023-00522-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Barth Dominik Andreas
-
Pichler Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Plain language summaryUrothelial carcinoma (UC) presents as aggressive disease with a greater incidence in men, yet a more aggressive course of disease in women. Patients with metastatic UC receive a chemotherapy regimen as the gold standard, based on an included platin substance. In the case of havi####
- Find related publications in this database (Keywords)
-
Metastatic urothelial carcinoma
-
Immunotherapy
-
Overall survival
-
Sex hormones
-
Gonadotropins
-
Prognostic
-
Biomarkers